Patents by Inventor Paula NORRIS

Paula NORRIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220380468
    Abstract: The present invention relates to the seminal discovery that BTLA agonist antibodies modulate the immune system. Specifically, the present invention provides antibodies which bind BTLA in the activated state enhancing BTLA signaling. The present invention further provides methods of treating immune and inflammatory diseases and disorders with a BTLA agonist antibody.
    Type: Application
    Filed: May 16, 2022
    Publication date: December 1, 2022
    Inventors: Carl F. WARE, John SEDY, Paula NORRIS
  • Patent number: 11352428
    Abstract: The present invention relates to the seminal discovery that BTLA agonist antibodies modulate the immune system. Specifically, the present invention provides antibodies which bind BTLA in the activated state enhancing BTLA signaling. The present invention further provides methods of treating immune and inflammatory diseases and disorders with a BTLA agonist antibody.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: June 7, 2022
    Assignee: Sanford Burnham Prebys Medical Discovery Institute
    Inventors: Carl F. Ware, John Sedy, Paula Norris
  • Publication number: 20180155426
    Abstract: The present invention relates to the seminal discovery that BTLA agonist antibodies modulate the immune system. Specifically, the present invention provides antibodies which bind BTLA in the activated state enhancing BTLA signaling. The present invention further provides methods of treating immune and inflammatory diseases and disorders with a BTLA agonist antibody.
    Type: Application
    Filed: April 29, 2016
    Publication date: June 7, 2018
    Inventors: Carl F. WARE, John SEDY, Paula NORRIS